Related Articles
Optimal antithrombotic therapy in patients with atrial fibrillation following percutaneous coronary intervention: A systemic review and meta-analysis
Influence of CYP2C19 genotype on antiplatelet treatment outcomes after percutaneous coronary intervention in patients with coronary heart disease
Analysis of thrombelastogram-guided medication in patients with coronary heart disease after percutaneous coronary intervention
Antiplatelet therapy with or without PPIs for the secondary prevention of cardiovascular diseases in patients at high risk of upper gastrointestinal bleeding: A systematic review and meta-analysis
Efficacy of arsenic trioxide drug‑eluting stents in the treatment of coronary heart disease